Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area
Estefanía Moreno, César Quiroz, William Rea, et al.
Journal of Neuroscience (2016) Vol. 37, Iss. 5, pp. 1176-1186
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 257
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences
Stefano Aringhieri, Marco Carli, Shivakumar Kolachalam, et al.
Pharmacology & Therapeutics (2018) Vol. 192, pp. 20-41
Closed Access | Times Cited: 177
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins
Estefanía Moreno, Júlia Canet, Eduard Gracia, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 59
Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Li Zhang, Jiangtao Zhang, Lihua Hang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 57
G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs)
Sergi Ferré, Francisco Ciruela, Carmen Dessauer, et al.
Pharmacology & Therapeutics (2021) Vol. 231, pp. 107977-107977
Open Access | Times Cited: 49
Opioid–galanin receptor heteromers mediate the dopaminergic effects of opioids
Ning-Sheng Cai, César Quiroz, Jordi Bonaventura, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 7, pp. 2730-2744
Open Access | Times Cited: 50
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer
Daniel Pulido, Verònica Casadó-Anguera, Laura Pérez‐Benito, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9335-9346
Open Access | Times Cited: 40
Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer
Paulo Alexandre de Oliveira, Estefanía Moreno, Nil Casajuana‐Martin, et al.
Pharmacological Research (2022) Vol. 182, pp. 106322-106322
Open Access | Times Cited: 20
G Protein–Coupled Receptor Heteromers in Brain: Functional and Therapeutic Importance in Neuropsychiatric Disorders
Yang Sun, Ahmed Hasbi, Susan R. George
The Annual Review of Pharmacology and Toxicology (2025) Vol. 65, Iss. 1, pp. 215-236
Closed Access
Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Müzeyyen Ugur, Lyes Derouiche, Dominique Massotte
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 36
Neuropeptide modulation of addiction: Focus on galanin
Shannyn G. Genders, Karlene J. Scheller, Elvan Djouma
Neuroscience & Biobehavioral Reviews (2018) Vol. 110, pp. 133-149
Closed Access | Times Cited: 24
Complexes of Ghrelin GHS-R1a, GHS-R1b, and Dopamine D1Receptors Localized in the Ventral Tegmental Area as Main Mediators of the Dopaminergic Effects of Ghrelin
Gemma Navarro, William Rea, César Quiroz, et al.
Journal of Neuroscience (2021) Vol. 42, Iss. 6, pp. 940-953
Open Access | Times Cited: 19
Underpinning the Neurobiological Intricacies Associated with Opioid Tolerance
Ankit Uniyal, Anagha Gadepalli, Akhilesh Akhilesh, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 6, pp. 830-839
Closed Access | Times Cited: 19
Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities
Marion Gaborit, Dominique Massotte
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 994-1013
Open Access | Times Cited: 16
Role of placebo effects in pain and neuropsychiatric disorders
Annabelle M. Belcher, Sergi Ferré, Pedro E. Martinez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 87, pp. 298-306
Open Access | Times Cited: 21
G protein-coupled receptor heteromers are key players in substance use disorder
Lyes Derouiche, Dominique Massotte
Neuroscience & Biobehavioral Reviews (2018) Vol. 106, pp. 73-90
Open Access | Times Cited: 19
Endogenous opiates and behavior: 2017
Richard J. Bodnar
Peptides (2019) Vol. 124, pp. 170223-170223
Closed Access | Times Cited: 18
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Unmasking allosteric-binding sites: novel targets for GPCR drug discovery
Verònica Casadó-Anguera, Vicent Casadó
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 8, pp. 897-923
Closed Access | Times Cited: 10
The µ‐Opioid Receptor in Cancer and Its Role in Perineural Invasion: A Short Review and New Evidence
Juan P. Cata, Megan L. Uhelski, Ayşegül Görür, et al.
Advanced Biology (2022) Vol. 6, Iss. 9
Closed Access | Times Cited: 8
The Dopaminergic System in the Ventral Tegmental Area Contributes to Morphine Analgesia and Tolerance
Jihong Wang, Zheng Li, Ye Tu, et al.
Neuroscience (2023) Vol. 527, pp. 74-83
Open Access | Times Cited: 4
The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome
Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, et al.
Advances in pharmacology (2019), pp. 37-78
Closed Access | Times Cited: 11
Against Repurposing Methadone for Glioblastoma Therapy
Tatjana Vatter, Lukas Klumpp, Katrin Ganser, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 917-917
Open Access | Times Cited: 11
Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top